These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4447098)

  • 21. [Presentation of a female patient with hepatic coma cured by treatment with L-Dopa].
    Sarrazin A; Emerit J; Olivier L; Rebelo R; Bousquet O
    Rev Neurol (Paris); 1971 Nov; 125(5):391-3. PubMed ID: 5153293
    [No Abstract]   [Full Text] [Related]  

  • 22. Early detection of L-dopa response in parkinsonian patients with a standardized tracking test.
    Albani C; Buck A
    Adv Neurol; 1993; 60():386-9. PubMed ID: 8420158
    [No Abstract]   [Full Text] [Related]  

  • 23. Excretion of amines and their metabolites by two patients in hepatic coma treated with L-dopa.
    Tyce GM; Stockard J; Sharpless NS; Muenter MD
    Clin Pharmacol Ther; 1983 Sep; 34(3):390-8. PubMed ID: 6883916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spectral analysis of the EEG in hepatic encephalopathy treated with levodopa.
    Yaar I; Shapiro MB; Pottala EW
    Electroencephalogr Clin Neurophysiol; 1981 Dec; 52(6):617-25. PubMed ID: 6172261
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of acute and chronic hepatic encephalopathy in cirrhosis].
    Doffoel M; Bockel R
    Ann Gastroenterol Hepatol (Paris); 1984; 20(3):163-6. PubMed ID: 6529174
    [No Abstract]   [Full Text] [Related]  

  • 26. Standard and higher doses of bromocriptine for severe chronic portal-systemic encephalopathy.
    Uribe M; García-Ramos G; Ramos M; Valverde C; Márquez MA; Farca A; Guevara L
    Am J Gastroenterol; 1983 Aug; 78(8):517-22. PubMed ID: 6881119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychomotor, neuroendocrine and behavioural effects after oral administration of levodopa in normal volunteers.
    Sabbe B; Hulstijn W; Maes M; Pier M; Scharpé S; Zitman F
    Psychiatry Res; 2004 Aug; 128(1):103-6. PubMed ID: 15450919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Levodopa as a single treatment of Parkinsonism. Long-term control of 24 cases with discrimination analysis].
    Borromei A; Manzini A
    Minerva Med; 1974 Nov; 65(79):4160-70. PubMed ID: 4610450
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hepatic coma. Treatment with L-dopa. Preliminary report].
    Hernández Peniche J; González Posada JC; Tirado Arroyave S
    Prensa Med Mex; 1972; 37(5):161-2. PubMed ID: 5069454
    [No Abstract]   [Full Text] [Related]  

  • 30. Cognitive deficits associated with chronic hepatic encephalopathy and their response to levodopa.
    Elithorn A; Lunzer M; Weinman J
    J Neurol Neurosurg Psychiatry; 1975 Aug; 38(8):794-8. PubMed ID: 1185200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in brain amines following portal flow diversion and acute hepatic coma: effects of levodopa (L-dopa) and intestinal sterilization.
    Fischer JE; James JH; Baldessarini R
    Surg Forum; 1972; 23(0):348-50. PubMed ID: 4601328
    [No Abstract]   [Full Text] [Related]  

  • 32. Hepatic encephalopathy treated with L-dopa, recovery followed for 18 months.
    Colón AR; Sandburg DH
    Pediatrics; 1973 Jun; 51(6):1105-6. PubMed ID: 4710450
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of hepatic coma].
    Salaspuro M
    Duodecim; 1976; 92(5):252-6. PubMed ID: 1261440
    [No Abstract]   [Full Text] [Related]  

  • 34. [Therapeutic effect of L-ornithine-L-aspartate on liver cirrhosis complicated by hepatic encephalopathy].
    Chen MF; Li RC; Chen CH; Gao XC
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):718-9, 722. PubMed ID: 15958319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. L-dopa in hepatic coma.
    Fischer JE; Funovics FJ; Falcao HA; Wesdorp RI
    Ann Surg; 1976 Apr; 183(4):386-91. PubMed ID: 1267495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Holmes tremor secondary to brainstem hemorrhage responsive to levodopa: report of 2 cases.
    Raina GB; Velez M; Pardal MF; Micheli F
    Clin Neuropharmacol; 2007; 30(2):95-100. PubMed ID: 17414941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levodopa in fulminant hepatic failure: preliminary report.
    Datta DV; Maheshwari YK; Aggarwal ML
    Am J Med Sci; 1976; 272(1):95-9. PubMed ID: 961722
    [No Abstract]   [Full Text] [Related]  

  • 38. Variations in L-dopa absorption. Report of a parkinsonian patient with high plasma dopa concentration after therapeutical L-dopa dose.
    Granerus AK; Jagenburg R; Rödjer S; Svanborg A
    Acta Med Scand; 1974 Dec; 196(6):459-63. PubMed ID: 4456974
    [No Abstract]   [Full Text] [Related]  

  • 39. Glottographic measures before and after levodopa treatment in Parkinson's disease.
    Jiang J; Lin E; Wang J; Hanson DG
    Laryngoscope; 1999 Aug; 109(8):1287-94. PubMed ID: 10443835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parkinsonian action tremor: interference with object manipulation and lacking levodopa response.
    Raethjen J; Pohle S; Govindan RB; Morsnowski A; Wenzelburger R; Deuschl G
    Exp Neurol; 2005 Jul; 194(1):151-60. PubMed ID: 15899252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.